Ezh2 does not mediate retinal ganglion cell homeostasis or their susceptibility to injury.
Epigenetic predisposition is thought to critically contribute to adult-onset disorders, such as retinal neurodegeneration. The histone methyltransferase, enhancer of zeste homolog 2 (Ezh2), is transiently expressed in the perinatal retina, particularly enriched in retinal ganglion cells (RGCs). We p...
| 發表在: | PLoS ONE |
|---|---|
| Main Authors: | , , , , , , , , , , |
| 格式: | Article |
| 語言: | 英语 |
| 出版: |
Public Library of Science (PLoS)
2018-01-01
|
| 在線閱讀: | http://europepmc.org/articles/PMC5800601?pdf=render |
| _version_ | 1857033099551965184 |
|---|---|
| author | Lin Cheng Lucy J Wong Naihong Yan Richard C Han Honghua Yu Chenying Guo Khulan Batsuuri Aniket Zinzuwadia Ryan Guan Kin-Sang Cho Dong Feng Chen |
| author_facet | Lin Cheng Lucy J Wong Naihong Yan Richard C Han Honghua Yu Chenying Guo Khulan Batsuuri Aniket Zinzuwadia Ryan Guan Kin-Sang Cho Dong Feng Chen |
| author_sort | Lin Cheng |
| collection | DOAJ |
| container_title | PLoS ONE |
| description | Epigenetic predisposition is thought to critically contribute to adult-onset disorders, such as retinal neurodegeneration. The histone methyltransferase, enhancer of zeste homolog 2 (Ezh2), is transiently expressed in the perinatal retina, particularly enriched in retinal ganglion cells (RGCs). We previously showed that embryonic deletion of Ezh2 from retinal progenitors led to progressive photoreceptor degeneration throughout life, demonstrating a role for embryonic predisposition of Ezh2-mediated repressive mark in maintaining the survival and function of photoreceptors in the adult. Enrichment of Ezh2 in RGCs leads to the question if Ezh2 also mediates gene expression and function in postnatal RGCs, and if its deficiency changes RGC susceptibility to cell death under injury or disease in the adult. To test this, we generated mice carrying targeted deletion of Ezh2 from RGC progenitors driven by Math5-Cre (mKO). mKO mice showed no detectable defect in RGC development, survival, or cell homeostasis as determined by physiological analysis, live imaging, histology, and immunohistochemistry. Moreover, RGCs of Ezh2 deficient mice revealed similar susceptibility against glaucomatous and acute optic nerve trauma-induced neurodegeneration compared to littermate floxed or wild-type control mice. In agreement with the above findings, analysis of RNA sequencing of RGCs purified from Ezh2 deficient mice revealed few gene changes that were related to RGC development, survival and function. These results, together with our previous report, support a cell lineage-specific mechanism of Ezh2-mediated gene repression, especially those critically involved in cellular function and homeostasis. |
| format | Article |
| id | doaj-art-059db07025ac45358eef4b0f6f177cf2 |
| institution | Directory of Open Access Journals |
| issn | 1932-6203 |
| language | English |
| publishDate | 2018-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| spelling | doaj-art-059db07025ac45358eef4b0f6f177cf22025-08-19T19:39:28ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01132e019185310.1371/journal.pone.0191853Ezh2 does not mediate retinal ganglion cell homeostasis or their susceptibility to injury.Lin ChengLucy J WongNaihong YanRichard C HanHonghua YuChenying GuoKhulan BatsuuriAniket ZinzuwadiaRyan GuanKin-Sang ChoDong Feng ChenEpigenetic predisposition is thought to critically contribute to adult-onset disorders, such as retinal neurodegeneration. The histone methyltransferase, enhancer of zeste homolog 2 (Ezh2), is transiently expressed in the perinatal retina, particularly enriched in retinal ganglion cells (RGCs). We previously showed that embryonic deletion of Ezh2 from retinal progenitors led to progressive photoreceptor degeneration throughout life, demonstrating a role for embryonic predisposition of Ezh2-mediated repressive mark in maintaining the survival and function of photoreceptors in the adult. Enrichment of Ezh2 in RGCs leads to the question if Ezh2 also mediates gene expression and function in postnatal RGCs, and if its deficiency changes RGC susceptibility to cell death under injury or disease in the adult. To test this, we generated mice carrying targeted deletion of Ezh2 from RGC progenitors driven by Math5-Cre (mKO). mKO mice showed no detectable defect in RGC development, survival, or cell homeostasis as determined by physiological analysis, live imaging, histology, and immunohistochemistry. Moreover, RGCs of Ezh2 deficient mice revealed similar susceptibility against glaucomatous and acute optic nerve trauma-induced neurodegeneration compared to littermate floxed or wild-type control mice. In agreement with the above findings, analysis of RNA sequencing of RGCs purified from Ezh2 deficient mice revealed few gene changes that were related to RGC development, survival and function. These results, together with our previous report, support a cell lineage-specific mechanism of Ezh2-mediated gene repression, especially those critically involved in cellular function and homeostasis.http://europepmc.org/articles/PMC5800601?pdf=render |
| spellingShingle | Lin Cheng Lucy J Wong Naihong Yan Richard C Han Honghua Yu Chenying Guo Khulan Batsuuri Aniket Zinzuwadia Ryan Guan Kin-Sang Cho Dong Feng Chen Ezh2 does not mediate retinal ganglion cell homeostasis or their susceptibility to injury. |
| title | Ezh2 does not mediate retinal ganglion cell homeostasis or their susceptibility to injury. |
| title_full | Ezh2 does not mediate retinal ganglion cell homeostasis or their susceptibility to injury. |
| title_fullStr | Ezh2 does not mediate retinal ganglion cell homeostasis or their susceptibility to injury. |
| title_full_unstemmed | Ezh2 does not mediate retinal ganglion cell homeostasis or their susceptibility to injury. |
| title_short | Ezh2 does not mediate retinal ganglion cell homeostasis or their susceptibility to injury. |
| title_sort | ezh2 does not mediate retinal ganglion cell homeostasis or their susceptibility to injury |
| url | http://europepmc.org/articles/PMC5800601?pdf=render |
| work_keys_str_mv | AT lincheng ezh2doesnotmediateretinalganglioncellhomeostasisortheirsusceptibilitytoinjury AT lucyjwong ezh2doesnotmediateretinalganglioncellhomeostasisortheirsusceptibilitytoinjury AT naihongyan ezh2doesnotmediateretinalganglioncellhomeostasisortheirsusceptibilitytoinjury AT richardchan ezh2doesnotmediateretinalganglioncellhomeostasisortheirsusceptibilitytoinjury AT honghuayu ezh2doesnotmediateretinalganglioncellhomeostasisortheirsusceptibilitytoinjury AT chenyingguo ezh2doesnotmediateretinalganglioncellhomeostasisortheirsusceptibilitytoinjury AT khulanbatsuuri ezh2doesnotmediateretinalganglioncellhomeostasisortheirsusceptibilitytoinjury AT aniketzinzuwadia ezh2doesnotmediateretinalganglioncellhomeostasisortheirsusceptibilitytoinjury AT ryanguan ezh2doesnotmediateretinalganglioncellhomeostasisortheirsusceptibilitytoinjury AT kinsangcho ezh2doesnotmediateretinalganglioncellhomeostasisortheirsusceptibilitytoinjury AT dongfengchen ezh2doesnotmediateretinalganglioncellhomeostasisortheirsusceptibilitytoinjury |
